Influenza vaccine with additional H3 antigen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza vaccine with additional H3 antigen, covering 2025-09-11 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older [Phase 1]